Hypertrophic Cardiomyopathy: History and Future Directions

Webinar

Webinar Overview

This webinar will cover the history of hypertrophic cardiomyopathy (HCM), including prevalence data, risk stratification and outcomes. We will explore how to screen for and diagnose the disease. The presentation will include a discussion of treatment options for patients with clinical signs and an exciting new treatment option for subclinical pets.

Learning Objectives

Describe the prevalence and explain how HCM is diagnosed.
Understand the lifetime risks of cardiac events in a population of cats with HCM.
Gain an understanding of treatment options for clinical patients and the mechanism of Felicyn-CA1.

Registration

Registration for the webinar is now open.

Speaker

Sarah Bell

DVM, MS, DACVIM (Cardiology)

Sarah Bell, DVM, MS, DACVIM (Cardiology)
CVCA Cardiac Care for Pets

Dr. Bell graduated from the University of Georgia in 2009 and completed a rotating internship at NC State University the following year. After a year in emergency practice in Pittsburgh, she joined the cardiology team at the University of Missouri, finishing a cardiology internship followed by a joint cardiology residency and Master of Veterinary Science program in 2015.

Webinar Information

Date: November 6, 2025
Start time: 5:00 pm MT
End time: 6:30 pm MT
Location: Live, Virtual and On Demand
Audience: ACVIM Diplomates and Candidates, European affiliate partners Diplomates and Candidates, Specialty Technicians
Specialty: Cardiology and SAIM
Type: Webinar

RACE Application Status:

This webinar has been approved for 1.5 live, interactive-distance, medical continuing education credit in jurisdictions which recognize AAVSB RACE-approval.

For additional questions, please contact us at Learning@ACVIM.org.